Safety and Efficacy of C21 in Subjects With COVID-19
Clinical trial NCT04452435 · COMPLETED
Trial details
- NCT number
- NCT04452435
- Sponsor
- Vicore Pharma AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-21
- Primary completion
- 2020-10-13
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.